New Drug May Brighten Outlook for Advanced Breast Cancer
A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms.

The drug, called palbociclib (Ibrance), was approved in the United States last year for treating advanced cases of ER-positive breast cancer. That means the cancer uses the hormone estrogen to help fuel its growth...
https://www.drugs.com/news/new-may-brighten-outlook-advanced-breast-cancer-63449.html?utm_source=ddc&utm_medium=rss&utm_campaign=New+Drug+May+Brighten+Outlook+for+Advanced+Breast+Cancer
Like
Comment
Share